Job Detail

Job Position - Department

Treatment Supporter Coordinator - endTB - GHD

Experience

Minimum of 1-year experience in the field of community engagement

Education

Matric, Intermediate (preferred)

Last Date

2/17/2019 12:00:00 AM

Job Description

The incumbent is to provide support to the pharmacist of a phase III randomized controlled trial. They will assist with management of the trial pharmacy, in accordance with Drug Regulatory Authority of Pakistan (DRAP), Good Clinical Practice (GCP), and Good Pharmacy Practice (GPP) guidelines.

Undergo training in the protocol, trial procedures, and GCP.
• Travel to trial clinic sites and conduct patient home visits in Karachi.
• Carry out home visits for endTB patients in order to educate the family on the trial and TB regimen, to provide psychosocial support if needed, to identify close contacts at high risk of DR-TB, and to identify and address infection control concerns in the home.
• Carry out home visits in case of medical or adherence problems and to take necessary actions to retrieve non adherent and potential lost to follow up patients.
• Assist in tracing patients following treatment interruption and returning them to care.
• Identification of appropriate treatment supporter for the patient.
• Coordinate all MDR TB ambulatory activities.
• Coordinate with Provincial MDR TB Coordinator of respective district to retrieve lost to follow up cases (if needed).
• Identify and address socioeconomic problems.
• Provision of training to treatment supporter.
• Supervise DR TB supporter and ensure Directly observed treatment (DOT) forms are filled on a daily basis by the supporter.
• Coordinate with clinical, data and pharmacy staff.
• Handing over weekly blister packs (treatment supply) to treatment supporter with the support of the pharmacist and maintaining records per guidelines. 
• Complete all recording documents as required by endTB trial SOPs.
• To provide emotional, psychosocial, and educational support (during working hours) as required throughout the treatment journey for patients enrolled onto the endTB trial. 
• Assist the team with collection of specific missing data for individual endTB patients if possible.